Literature DB >> 8636272

The frequency of macroprolactinemia in pregnant women and the heterogeneity of its etiologies.

N Hattori1.   

Abstract

We surveyed pregnant women for macroprolactinemia and examined the heterogeneity of its etiologies. Serum samples obtained from 105 pregnant women (29.7 +/- 4.4 yr) during the third trimester were treated with polyethylene glycol, and 3 women (2.9%) were found to have a significantly high proportion of precipitated prolactin (PRL). Gel filtration studies revealed that big-big PRL (molecular weight greater than 100,000) was predominant (63.6, 74.0, 43.5% vs. 0.3 +/- 0.2% in normal pregnant women). The common clinical features of the 3 women included idiopathic hyperprolactinemia without any clinical symptoms such as amenorrhea and galactorrhea before pregnancy and very high levels of PRL (1680, 793, and 790 micrograms/L vs. 315 +/- 112 micrograms/L in normal pregnant women) during pregnancy. However, the nature of big-big PRL was different. Two of the 3 women possessed anti-PRL autoantibody (125I-PRL binding to the serum: 17.6%, 18.6% vs. 6.9 +/- 1.6% in normal pregnant women), but the other one did not have it. A significantly high proportion of PRL was absorbed to a concanavalin A column (41.1% vs. 4.0 +/- 2.1% in normal pregnant women), repetitive freezing and thawing of isolated big-big PRL resulted in a partial conversion to big and little PRL, and reduction of the isolated big-big PRL with 2-mercaptoethanol almost completely converted big-big PRL to little PRL in this woman. These findings suggest that this woman had a heterogeneous complex of covalently and noncovalently bound form of PRL with increased glycosylation. We conclude that macroprolactinemia is present with considerable frequency in pregnant women and that different etiologies are involved to form big-big PRL in macroprolactinemia.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8636272     DOI: 10.1210/jcem.81.2.8636272

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  10 in total

1.  Prevalence and reproductive manifestations of macroprolactinemia.

Authors:  Amanpreet Kaur Kalsi; Ashutosh Halder; Manish Jain; P K Chaturvedi; J B Sharma
Journal:  Endocrine       Date:  2018-09-29       Impact factor: 3.633

Review 2.  Neuroendocrine causes of amenorrhea--an update.

Authors:  Lindsay T Fourman; Pouneh K Fazeli
Journal:  J Clin Endocrinol Metab       Date:  2015-01-12       Impact factor: 5.958

3.  Identification of IgG-immunocomplex macroprolactin with an immunometric "sandwich" system: technical and clinical considerations.

Authors:  P Amadori; C Dilberis; A Marcolla; M Pinamonti; P Menapace; A Valentini
Journal:  J Endocrinol Invest       Date:  2004-12       Impact factor: 4.256

4.  Macroprolactinemia: predictability on clinical basis and detection by PEG precipitation with two different immunometric methods.

Authors:  P Amadori; C Dilberis; A Marcolla; M Pinamonti; P Menapace; F Dal Bosco
Journal:  J Endocrinol Invest       Date:  2003-02       Impact factor: 4.256

5.  Metabolic, endocrinologic and cardiac effects of amisulpride: a 24-week follow-up study.

Authors:  Zeynep Kotan; Berrin Ertepe; Cengiz Akkaya; Emre Sarandol; Güven Ozkaya; Selçuk Kirli
Journal:  Ther Adv Psychopharmacol       Date:  2011-12

6.  Macroprolactinemia: the consequences of a laboratory pitfall.

Authors:  Erzsébet Toldy; Zoltán Löcsei; István Szabolcs; Miklós I Góth; Pál Kneffel; Dominika Szöke; Gábor L Kovács
Journal:  Endocrine       Date:  2003-12       Impact factor: 3.633

7.  Macroprolactinemia and Empty Sella Syndrome.

Authors:  Ach Taieb; Kacem Njah Maha; Yosra Hasni El Abed; Amel Maaroufi Beizig; Molka Chaieb Chadli; Koussay Ach
Journal:  Pan Afr Med J       Date:  2017-08-14

Review 8.  Macroprolactinemia: diagnostic, clinical, and pathogenic significance.

Authors:  Akira Shimatsu; Naoki Hattori
Journal:  Clin Dev Immunol       Date:  2012-12-04

9.  Serum macroprolactin levels in pregnancy and association with thyroid autoimmunity.

Authors:  Metin Guclu; Soner Cander; Sinem Kiyici; Ebru Vatansever; Arif Bayram Hacihasanoğlu; Gurcan Kisakol
Journal:  BMC Endocr Disord       Date:  2015-06-20       Impact factor: 2.763

10.  Macroprolactin; a frequent cause of misdiagnosed hyperprolactinemia in clinical practice.

Authors:  Vaishya Richa; Gupta Rahul; Arora Sarika
Journal:  J Reprod Infertil       Date:  2010-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.